+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Regulation of somatostatin release by adenosine in the mouse stomach



Regulation of somatostatin release by adenosine in the mouse stomach



Journal of Pharmacology and Experimental Therapeutics 329(2): 729-737



Adenosine inhibits gastric acid secretion, either directly by acting on acid-secreting parietal cells or indirectly by stimulating the release of the acid inhibitor, somatostatin. The present study examined the role of adenosine on somatostatin release in an isolated vascularly perfused mouse stomach model. Concentrations of exogenous adenosine >or= 1.0 microM stimulated gastric release of somatostatin-like immunoreactivity (SLI), and this effect was blocked by the A(2A) receptor antagonist ZM 241385 [4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol]. The A(2A) receptor agonist CGS 21680 [2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine hydrochloride] augmented SLI release in a concentration-dependent manner, suggesting that A(2A) receptor activation is involved in the stimulatory effect of adenosine on SLI release. Conversely, SLI release was inhibited by the A(1) receptor agonists N(6)-cyclopentyladenosine and 2-chloro-N(6)-cyclopentyladenosine and lower concentration of adenosine (0.01 microM). The involvement of specific adenosine receptors in controlling the release of gastric SLI was also examined using A(2A) receptor knockout (A(2A)R-KO) mice. In these mice, adenosine (10 microM) inhibited SLI release, and the effect was abolished by the selective A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine, suggesting a link between the selective A(1) activation and inhibition of SLI release. The adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride augmented SLI release in wild-type controls but not in the presence of ZM 241385 or in A(2A)R-KO mice. We conclude that adenosine has dual actions on regulating mouse gastric SLI release: stimulatory at higher concentrations through the A(2A) receptor and inhibitory at lower concentrations through the A(1) receptor, whereas A(2B) and A(3) receptors have a minimal role.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055453851

Download citation: RISBibTeXText

PMID: 19208896

DOI: 10.1124/jpet.108.146050


Related references

Role of adenosine A2A receptor in the regulation of gastric somatostatin release. Journal of Pharmacology and Experimental Therapeutics 309(2): 804-815, 2004

Mechanisms for regulation of gastrin and somatostatin release from isolated rat stomach during gastric distention. World Journal of Gastroenterology 9(1): 129-133, 2003

Antisecretory effect of somatostatin on gastric acid via inhibition of histamine release in isolated mouse stomach. European Journal of Pharmacology 452(2): 235-243, 4 October, 2002

Involvement of intrinsic calcitonin gene related peptide cgrp in regulation of somatostatin release from rat stomach. Digestion 46(Suppl. 1): 19, 1990

Involvement of adenosine signaling in controlling the release of ghrelin from the mouse stomach. Journal of Pharmacology and Experimental Therapeutics 336(1): 77-86, 2011

Role of endogenous somatostatin and cholinergic mechanisms for regulation of gastrin release from the isolated rat stomach during gastric distention. Gastroenterology 122(4 Suppl 1): A-255, 2002

Regulation of gastrin, somatostatin and bombesin release from the isolated rat stomach by exogenous and endogenous gamma-aminobutyric acid. Digestion 59(1): 16-25, 1998

Effects of somatostatin and urotensin II on tilapia pituitary prolactin release and interactions between somatostatin, osmotic pressure Ca++, and adenosine 3',5'-monophosphate in prolactin release in vitro. Endocrinology 110(3): 910-915, 1982

Somatostatin-14 and somatostatin-28 pretreatment down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimulated cyclic adenosine, 3',5'-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pituitary tumor cells. Endocrinology 117(1): 217-225, 1985

Augmentation of release of gastric somatostatin-like immunoreactivity by adenosine, adenosine triphosphate and their analogs. Journal of Pharmacology and Experimental Therapeutics 255(2): 781-788, 1990

Somatostatin inhibition of cyclic AMP accumulation and adrenocorticotropin release from mouse anterior pituitary tumor cells: mode of action and self-regulation. Advances in Cyclic Nucleotide and Protein Phosphorylation Research 19: 169-177, 1985

Somatostatin inhibition of cyclic amp accumulation and acth release from mouse anterior pituitary tumor cells mode of action and self regulation. Cooper, D M F And K B Seamon (Ed ) Advances in Cyclic Nucleotide And Protein Phosphorylation Research, Vol 19 Dual Regulation Of Adenylate Cyclase Xvii+334p Raven Press: New York, N Y , Usa Illus 169-178, 1985

The role of adenosine A(2) receptors in the regulation of TNF-alpha production and PGE(2) release in mouse peritoneal macrophages. International Immunopharmacology 7(4): 483-490, 2007

Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina. Naunyn-Schmiedeberg's Archives of Pharmacology 367(2): 188-192, 2003

Secretion of somatostatin by rat islets of Langerhans and gastric mucosa and a role for pancreatic somatostatin in the regulation of glucagon release. Metabolism: Clinical and Experimental 27(9 Suppl 1): 1215-1218, 1978